@inproceedings{inproceedings, title  = {{LABORATORY SAFETY OF DUPILUMAB IN PEDIATRIC PATIENTS AGED >= 6-< 12 YEARS WITH SEVERE ATOPIC DERMATITIS: RESULTS FROM A PHASE 3 TRIAL (LIBERTY AD PEDS)}},

 url = {{}},

 year = {{2021}},

 month = {{1}},

 author = {{Wollenberg A and Thaci D and Cork MJ and Arkwright PD and Gooderham M and Sun X and O'Malley JT and Khokhar FA and Bansal A and Shumel B}},

 volume = {{101}},

 journal = {{ACTA DERMATO-VENEREOLOGICA}},

 pages = {{59-59}},

 note = {{Accessed on 2024/12/22}}}